StockData

Earnings calendar

US companies reporting quarterly results in the week of Mar 27 – Mar 31, 2023. Reported figures come from each company's earnings release filed with the SEC; expected dates are estimated from when the company reported in past years.

251 companies · 251 reported

Monday, March 27, 2023

26 companies, largest first · 7 before the open, 16 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
cclCarnivalBefore openQ1 FY2023$42.11B$4.40B$1.62B+171.1%-$0.55-$1.66Release ↗
bntxBioNTechBefore openQ4 FY2022$22.78B–––––Release ↗
hthtH WorldBefore openQ4 FY2022$15.43B–––––Release ↗
pvhPVHAfter closeQ4 FY2022$4.49B$2.49B$2.43B+2.4%$2.38$2.84Release ↗
tngxTango TherapeuticsBefore openQ4 FY2022$3.91B$6.40M$5.70M+12.3%-$0.33-$0.25Release ↗
rgtiRigetti ComputingDuring marketQ4 FY2022$3.74B$6.10M––-$0.19–Release ↗
rhRHAfter closeQ4 FY2022$2.74B–––––Release ↗
grntGranite Ridge ResourcesAfter closeQ4 FY2022$610.70M–––$0.38–Release ↗
oggOsisko GoldAfter closeQ4 FY2022$601.97M–––––Release ↗
dcthDelcath SystemsAfter closeQ4 FY2022$514.24M–$200.00K––-$0.69Release ↗
ctmxCytomX TherapeuticsAfter closeQ4 FY2022$512.06M–$19.70M–––Release ↗
scnxScientureAfter closeQ4 FY2022$140.44M–$2.40M––-$0.10Release ↗
idxgInterpace BiosciencesAfter closeQ4 FY2022$138.50M–––––Release ↗
railFreightCar AmericaAfter closeQ4 FY2022$137.72M$129.00M$75.00M+72.0%-$0.31$0.06Release ↗
okurOnKure TherapeuticsAfter closeQ4 FY2022$104.89M–––-$0.56-$0.43Release ↗
wyyWidePointAfter closeQ4 FY2022$67.19M$23.30M$24.50M−4.9%-$1.02-$0.06Release ↗
rekrRekor SystemsAfter closeQ4 FY2022$49.33M–––––Release ↗
nxglNexgelAfter closeQ4 FY2022$39.09M$524.00K$533.00K−1.7%––Release ↗
naasNaaS TechnologyDuring marketQ4 FY2022$20.90M–––––Release ↗
inlxIntellineticsAfter closeQ4 FY2022$18.45M$4.04M$2.74M+47.2%$0.04$0.01Release ↗
abosAcumen PharmaceuticalsBefore openQ4 FY2022$15.64M–––––Release ↗
xcurExicureDuring marketQ4 FY2022$6.50M–––––Release ↗
jagxJaguar HealthBefore openQ4 FY2022$2.89M$3.30M$2.10M+57.1%––Release ↗
giprGeneration Income PropertiesAfter closeQ4 FY2022$542.76K$1.40M$900.00K+55.3%-$0.39-$1.34Release ↗
vislVislink TechnologiesAfter closeQ4 FY2022––––––Release ↗

Tuesday, March 28, 2023

42 companies, largest first · 17 before the open, 17 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
muMicron TechnologyAfter closeQ2 FY2023$898.12B$3.69B$7.79B−52.6%-$1.91$2.14Release ↗
snxTd SynnexBefore openQ1 FY2023$18.42B$15.10B$15.50B−2.6%$2.93$3.03Release ↗
mkcMcCormickBefore openQ1 FY2023$13.54B$1.57B$1.52B+2.8%$0.59$0.63Release ↗
lululululemon athleticaAfter closeQ4 FY2022$11.83B$2.80B$2.10B+33.3%$4.40$3.37Release ↗
jefJefferies FinancialAfter closeQ1 FY2023$11.20B$1.28B$1.73B−26.1%$0.54$1.23Release ↗
drsLeonardo DRSBefore openQ4 FY2022$9.48B$820.00M––$0.35–Release ↗
cnmCore & MainBefore openQ4 FY2022$9.26B$1.37B$1.25B+10.3%$0.31$0.28Release ↗
kodKodiak SciencesDuring marketQ4 FY2022$6.19B–––-$1.35-$1.79Release ↗
eeExcelerate EnergyAfter closeQ4 FY2022$3.89B$455.10M––$0.25–Release ↗
calmCal-Maine FoodsAfter closeQ3 FY2023$3.18B$997.50M$477.50M+108.9%$6.62$0.81Release ↗
ihsIHSBefore openQ4 FY2022$2.85B–––––Release ↗
ncnonCinoAfter closeQ4 FY2023$2.48B$109.20M$75.00M+45.6%$0.04-$0.09Release ↗
veraVera TherapeuticsBefore openQ4 FY2022$2.30B––––-$0.79Release ↗
prgsProgress SoftwareAfter closeQ1 FY2023$1.83B$164.20M$144.90M+13.3%$1.19$0.97Release ↗
chrnChronoScaleAfter closeQ4 FY2022$1.75B$3.60M$4.10M−12.2%-$0.24-$0.23Release ↗
tshaTaysha Gene TherapiesDuring marketQ4 FY2022$1.42B$2.50M––-$0.99-$1.32Release ↗
crvsCorvus PharmaceuticalsDuring marketQ4 FY2022$889.16M–––-$0.21-$0.20Release ↗
dmacDiaMedica TherapeuticsDuring marketQ4 FY2022$580.78M–––––Release ↗
fthFaeth TherapeuticsBefore openQ4 FY2022$516.55M–––––Release ↗
noahNoahAfter closeQ4 FY2022$472.71M–––––Release ↗
prokProKidneyDuring marketQ4 FY2022$338.60M–––-$0.11–Release ↗
arctArcturus TherapeuticsAfter closeQ4 FY2022$308.96M$160.30M$5.80M+2663.8%$4.33-$1.47Release ↗
playDave & Buster's EntertainmentAfter closeQ4 FY2022$305.81M$563.80M$343.10M+64.3%–$0.52Release ↗
loveLovesacBefore openQ4 FY2023$248.23M$238.80M$196.20M+21.7%$1.74$2.03Release ↗
whwkWhitehawk TherapeuticsBefore openQ4 FY2022$180.72M$5.20M$1.00M+420.0%-$0.52-$0.77Release ↗

Wednesday, March 29, 2023

50 companies, largest first · 26 before the open, 17 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
ctasCintasBefore openQ3 FY2023$91.65B$2.19B$1.96B+11.7%$3.14$2.97Release ↗
payxPaychexBefore openQ3 FY2023$42.26B–$1.28B–$1.29$1.15Release ↗
smtcSemtechAfter closeQ4 FY2022$10.36B$167.50M$190.60M−12.1%$0.47$0.70Release ↗
plPlanet Labs PBCAfter closeQ4 FY2023$4.60B$53.00M$37.10M+42.9%-$0.08-$0.26Release ↗
unfUniFirstBefore openQ2 FY2023$4.54B$542.70M$486.70M+11.5%$0.95$0.97Release ↗
pvlaPalvella TherapeuticsBefore openQ4 FY2022$2.34B–––––Release ↗
rdwRedwireBefore openQ4 FY2022$1.93B$53.70M$32.68M+64.3%-$0.43-$0.55Release ↗
cnxcConcentrixAfter closeQ1 FY2023$1.89B$1.64B$1.54B+6.5%$2.56$2.85Release ↗
hymcHycroft MiningAfter closeQ4 FY2022$1.63B–––––Release ↗
cxmSprinklrAfter closeQ4 FY2023$1.59B$165.30M$135.70M+21.8%$0.06-$0.05Release ↗
jbioJade BiosciencesDuring marketQ4 FY2022$956.50M–––––Release ↗
tigrUP FintechBefore openQ4 FY2022$749.31M–––––Release ↗
tsatTelesatBefore openQ4 FY2022$585.73M–––––Release ↗
coe51Talk Online EducationBefore openQ4 FY2022$546.26M–––––Release ↗
cbioCrescent BiopharmaBefore openQ4 FY2022$513.33M–––––Release ↗
avtxAvalo TherapeuticsBefore openQ4 FY2022$379.16M–––––Release ↗
abeoAbeona TherapeuticsBefore openQ4 FY2022$243.03M–$3.00M––-$0.45Release ↗
chciComstock Holding CompaniesDuring marketQ4 FY2022$205.33M$9.30M––$0.13–Release ↗
pedPedevcoBefore openQ4 FY2022$201.22M–––––Release ↗
fcFranklin CoveyDuring marketQ2 FY2023$195.72M$61.80M$56.60M+9.2%$0.12$0.13Release ↗
ltbrLightbridgeAfter closeQ4 FY2022$167.06M–––––Release ↗
antxAN2 TherapeuticsAfter closeQ4 FY2022$160.38M–––-$0.61–Release ↗
dermJourney MedicalAfter closeQ4 FY2022$133.50M$16.00M$17.50M−8.6%-$0.17-$0.93Release ↗
mistMilestone PharmaceuticalsBefore openQ4 FY2022$96.17M$3.50M––-$0.31–Release ↗
mraiMarpaiDuring marketQ4 FY2022$85.32M–––––Release ↗

Thursday, March 30, 2023

79 companies, largest first · 26 before the open, 28 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
ionqIonQAfter closeQ4 FY2022$11.25B$3.80M$1.60M+137.5%-$0.09-$0.39Release ↗
wulfTeraWulfAfter closeQ4 FY2022$5.84B$9.60M––––Release ↗
brzeBrazeAfter closeQ4 FY2023$5.24B$98.70M$70.40M+40.2%-$0.14-$0.18Release ↗
bbBlackberryAfter closeQ4 FY2023$5.14B$151.00M$185.00M−18.4%-$0.02$0.01Release ↗
legnLegend BiotechAfter closeQ4 FY2022$4.21B–––––Release ↗
plsePulse BiosciencesAfter closeQ4 FY2022$4.07B-$9.00K$844.00K−101.1%-$0.25-$0.52Release ↗
kenKenonBefore openQ4 FY2022$3.29B–––––Release ↗
fulFuller H BDuring marketQ1 FY2023$2.83B$809.00M$857.00M−5.6%$0.55$0.80Release ↗
neogNeogenBefore openQ3 FY2023$2.72B$218.30M$128.24M+70.2%$0.12$0.13Release ↗
rumRUMAfter closeQ4 FY2022$2.53B$20.00M––$0.00–Release ↗
aehrAehr Test SystemsAfter closeQ3 FY2023$1.98B$17.20M$15.30M+12.4%$0.16$0.14Release ↗
absiAbsciAfter closeQ4 FY2022$1.80B$1.60M$1.50M+6.7%-$0.21-$0.28Release ↗
qubtQuantum ComputingAfter closeQ4 FY2022$1.46B–––––Release ↗
gpcrStructure TherapeuticsDuring marketQ4 FY2022$1.45B–––––Release ↗
oabiOmniAbDuring marketQ4 FY2022$753.12M$35.30M––$0.07–Release ↗
cadlCandel TherapeuticsBefore openQ4 FY2022$692.49M$31.00K––-$0.18–Release ↗
angoAngioDynamicsBefore openQ3 FY2023$515.17M$80.70M$74.00M+9.1%-$0.03$0.03Release ↗
crmdCorMedixBefore openQ4 FY2022$441.16M$29.70K$56.40K−47.3%-$0.20-$0.20Release ↗
xyfX FinancialDuring marketQ4 FY2022$387.74M–––––Release ↗
irdOpus GeneticsBefore openQ4 FY2022$355.25M$39.90M––$1.58-$0.35Release ↗
galtGalectin TherapeuticsBefore openQ4 FY2022$349.95M–––––Release ↗
vrnoVeranoBefore openQ4 FY2022$344.12M–––––Release ↗
mktwMarketWiseBefore openQ4 FY2022$336.79M$127.70M$146.70M−13.0%––Release ↗
kinsKingstone CompaniesAfter closeQ4 FY2022$290.68M–––––Release ↗
eldnEledon PharmaceuticalsDuring marketQ4 FY2022$219.41M–––$0.68-$0.59Release ↗

Friday, March 31, 2023

54 companies, largest first · 24 before the open, 14 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
astsAST SpaceMobileBefore openQ4 FY2022$13.86B–$6.22M–-$0.14-$0.06Release ↗
manuManchester UnitedDuring marketQ2 FY2023$3.94B–––––Release ↗
ironDisc MedicineBefore openQ4 FY2022$3.20B–––––Release ↗
bvsBioventusBefore openQ4 FY2022$960.33M$125.80M$130.40M−3.5%-$0.06$0.26Release ↗
psixPower Solutions InternationalDuring marketQ4 FY2022$915.01M$137.00M––$0.44-$0.25Release ↗
mtaMetalla Royalty & StreamingDuring marketQ4 FY2022$732.05M–––––Release ↗
egyVAALCO EnergyAfter closeQ4 FY2022$568.04M$96.59M––––Release ↗
entxEntera BioAfter closeQ4 FY2022$538.47M–––––Release ↗
grvyGravityBefore openQ4 FY2022$475.72M–––––Release ↗
cwcoConsolidated WaterDuring marketQ4 FY2022$438.59M$28.40M––––Release ↗
ngsNatural Gas ServicesDuring marketQ4 FY2022$373.41M$22.50M$18.00M+25.0%$7.80-$0.18Release ↗
sabsSAB BiotherapeuticsAfter closeQ4 FY2022$289.34M–––––Release ↗
elloEllomay CapitalDuring marketQ4 FY2022$259.09M–––––Release ↗
duotDuos TechnologiesAfter closeQ4 FY2022$177.19M$5.93M$3.72M+59.4%––Release ↗
strsStratus PropertiesBefore openQ4 FY2022$141.69M–––––Release ↗
acntAscent IndustriesBefore openQ4 FY2022$123.79M$81.60M$95.70M−14.7%$0.01$0.84Release ↗
ihiHumanBefore openQ4 FY2022$116.53MCN¥260.70MCN¥237.80M+9.6%0.75 CNY-0.12 CNYRelease ↗
nrxpNRX PharmaceuticalsBefore openQ4 FY2022$107.81M–––––Release ↗
uncyUnicycive TherapeuticsBefore openQ4 FY2022$104.46M–––––Release ↗
skyxSKYX PlatformsAfter closeQ4 FY2022$99.96M–––––Release ↗
mpuMega MatrixAfter closeQ4 FY2022$99.08M–––––Release ↗
jushJushiBefore openQ4 FY2022$98.85M–––––Release ↗
imdxInsight Molecular DiagnosticsDuring marketQ4 FY2022$86.72M$1.10M$3.60M−69.4%–-$0.39Release ↗
ampgAmpliTechDuring marketQ4 FY2022$74.51M–––––Release ↗
hourHour LoopAfter closeQ4 FY2022$53.86M–––––Release ↗

Times are as filed with the SEC (before 9:30 a.m. or after 4 p.m. Eastern). See each company's Earnings tab for its full history and guidance, or the dividend calendar. Market caps as of the close on Nov 4, 2026.